OR51E1 and neoplasm: Primary tumor cells from 5 SI-NET patients (supplementary Fig. 1A and supplementary Table 1) were treated for 72 h with 5 different concentrations of the OR51E1 agonist nonanoic acid, 1-nonanol (a structurally related non-agonist [18]) and medium with vehicle (DMSO).